Andrea Loewen - 12 May 2023 Form 4 Insider Report for REATA PHARMACEUTICALS INC

Role: SVP, Global Regulatory Affairs
Signature: /s/ Tracy Herson, attorney-in-fact
Issuer symbol: N/A
Transactions as of: 12 May 2023
Net transactions value: -$616,352
Form type: 4
Filing time: 16 May 2023, 16:17:17 UTC
Previous filing: 09 Mar 2023
Next filing: 18 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RETA	Class A common stock	Sale	$582,267	-6,750	-17%	$86.26	32,007	12 May 2023	Direct	F1
transaction	RETA	Class A common stock	Sale	$8,725	-103	-0.32%	$84.71	31,904	15 May 2023	Direct	F2
transaction	RETA	Class A common stock	Sale	$25,359	-313	-0.98%	$81.02	31,591	16 May 2023	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.02 to $86.365. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2	The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on one day at prices ranging from $86.02 to $86.365. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The sale reported on this line represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units.